Avidity Partners Management LP lessened its stake in Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 18.2% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 615,000 shares of the biotechnology company’s stock after selling 136,600 shares during the quarter. Blueprint Medicines accounts for approximately 2.1% of Avidity […]
Avidity Partners Management LP decreased its position in Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 18.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 615,000 shares of the biotechnology company’s stock after selling 136,600 shares during the quarter. Blueprint Medicines comprises […]
Shares of Blueprint Medicines Co. (NASDAQ:BPMC – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the seventeen research firms that are currently covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation, nine have given a buy recommendation and […]
Ares Management Co. (NYSE:ARES – Get Free Report) has been assigned a consensus recommendation of “Hold” from the thirteen brokerages that are currently covering the stock, MarketBeat Ratings reports. Seven analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 12-month target price among […]
Advisory Services Network LLC increased its position in BNY Mellon Core Bond ETF (NYSEARCA:BKAG – Free Report) by 31.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 68,420 shares of the company’s stock after purchasing an additional 16,300 shares […]